106 related articles for article (PubMed ID: 27180425)
1. NEW RENIN-INHIBITORS--STABILITY AND ACTIVITY DETERMINATION. PART III.
Marszałek D; Goldnik A; Winiecka I; Jaworski P; Mazurek AP
Acta Pol Pharm; 2016; 73(2):329-36. PubMed ID: 27180425
[TBL] [Abstract][Full Text] [Related]
2. NEW RENIN INHIBITORS - STABILITY AND ACTIVITY DETERMINATION. PART IV.
Marszalek D; Goldnik A; Winiecka I; Jaworsk P; Mazurek Aleksander P
Acta Pol Pharm; 2017 Mar; 74(2):393-399. PubMed ID: 29624244
[TBL] [Abstract][Full Text] [Related]
3. New renin inhibitors--stability and activity determination. Part I.
Marszałek D; Goldnik A; Mazurek AP; Winiecka I; Jaworskpi P
Acta Pol Pharm; 2014; 71(4):545-53. PubMed ID: 25272881
[TBL] [Abstract][Full Text] [Related]
4. New renin inhibitors--stability and activity determination. Part II.
Marszałek D; Goldnik A; Mazurek AP; Winiecka I; Jaworski P; Szerszań S; Kozikowska E; Pawlik T
Acta Pol Pharm; 2014; 71(4):555-61. PubMed ID: 25272882
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of potent, low molecular weight renin inhibitors.
Sueiras-Diaz J; Jones DM; Szelke M; Deinum J; Svensson L; Westerlund C; Sohtell M
J Pept Res; 1997 Oct; 50(4):248-61. PubMed ID: 9352463
[TBL] [Abstract][Full Text] [Related]
6. New renin inhibitors with pseudodipeptidic units in P(1)-P(1') and P(2')-P(3') positions.
Paruszewski R; Jaworski P; Winiecka I; Tautt J; Dudkiewicz J
Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):850-3. PubMed ID: 12045347
[TBL] [Abstract][Full Text] [Related]
7. Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.
Rahuel J; Rasetti V; Maibaum J; Rüeger H; Göschke R; Cohen NC; Stutz S; Cumin F; Fuhrer W; Wood JM; Grütter MG
Chem Biol; 2000 Jul; 7(7):493-504. PubMed ID: 10903938
[TBL] [Abstract][Full Text] [Related]
8. Novel renin inhibitors containing derivatives of N-alkylleucyl-β-hydroxy-γ-amino acids.
Winiecka I; Jaworski P; Mazurek AP; Marszałek D; Goldnik A; Sokulski D
J Pept Sci; 2016 Feb; 22(2):106-15. PubMed ID: 26780837
[TBL] [Abstract][Full Text] [Related]
9. New renin inhibitors containing novel analogues of statine.
Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
[TBL] [Abstract][Full Text] [Related]
10. New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions.
Paruszewski R; Jaworski P; Bodnar M; Dudkiewicz-Wilczyńska J; Roman I
Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1305-9. PubMed ID: 16204988
[TBL] [Abstract][Full Text] [Related]
11. Renin inhibitors. Improvements in the stability and biological activity of small peptides containing novel Leu-Val replacements.
Kleinert HD; Luly JR; Marcotte PA; Perun TJ; Plattner JJ; Stein H
FEBS Lett; 1988 Mar; 230(1-2):38-42. PubMed ID: 3280345
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability.
Plattner JJ; Marcotte PA; Kleinert HD; Stein HH; Greer J; Bolis G; Fung AK; Bopp BA; Luly JR; Sham HL
J Med Chem; 1988 Dec; 31(12):2277-88. PubMed ID: 3143010
[TBL] [Abstract][Full Text] [Related]
13. Discovery of renin inhibitors containing a simple aspartate binding moiety that imparts reduced P450 inhibition.
Lawhorn BG; Tran T; Hong VS; Morgan LA; Le BT; Harpel MR; Jolivette L; Diaz E; Schwartz B; Gross JW; Tomaszek T; Semus S; Concha N; Smallwood A; Holt DA; Kallander LS
Bioorg Med Chem Lett; 2017 Nov; 27(21):4838-4843. PubMed ID: 28985999
[TBL] [Abstract][Full Text] [Related]
14. New modified heterocyclic phenylalanine derivatives. Incorporation into potent inhibitors of human renin.
Ocain TD; Deininger DD; Russo R; Senko NA; Katz A; Kitzen JM; Mitchell R; Oshiro G; Russo A; Stupienski R
J Med Chem; 1992 Mar; 35(5):823-32. PubMed ID: 1548674
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibitors containing isosteric replacements of the amide bond connecting the P3 and P2 sites.
Kaltenbronn JS; Hudspeth JP; Lunney EA; Michniewicz BM; Nicolaides ED; Repine JT; RoarK WH; Stier MA; Tinney FJ; Woo PK
J Med Chem; 1990 Feb; 33(2):838-45. PubMed ID: 2405159
[TBL] [Abstract][Full Text] [Related]
16. Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogen.
Sham HL; Bolis G; Stein HH; Fesik SW; Marcotte PA; Plattner JJ; Rempel CA; Greer J
J Med Chem; 1988 Feb; 31(2):284-95. PubMed ID: 3276890
[TBL] [Abstract][Full Text] [Related]
17. Novel approach of fragment-based lead discovery applied to renin inhibitors.
Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
[TBL] [Abstract][Full Text] [Related]
18. trans-(3S,4S)-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part I: prime site exploration using an amino linker.
Lorthiois E; Cumin F; Ehrhardt C; Kosaka T; Sellner H; Ostermann N; Francotte E; Wagner T; Maibaum J
Bioorg Med Chem Lett; 2015 Apr; 25(8):1782-1786. PubMed ID: 25782742
[TBL] [Abstract][Full Text] [Related]
19. Novel renin inhibitors containing a non-peptide aminoalkanoyl moiety at P1-P1' position.
Winiecka I; Marszałek D; Goldnik A; Jaworski P; Mazurek AP
Pharmazie; 2014 Apr; 69(4):263-70. PubMed ID: 24791589
[TBL] [Abstract][Full Text] [Related]
20. trans-3,4-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part II: prime site exploration using an oxygen linker.
Sellner H; Cottens S; Cumin F; Ehrhardt C; Kosaka T; Lorthiois E; Ostermann N; Webb RL; Rigel DF; Wagner T; Maibaum J
Bioorg Med Chem Lett; 2015 Apr; 25(8):1787-1791. PubMed ID: 25754490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
